One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Long COVID: the elephant in the room
doi : 10.1016/S2213-8587(22)00111-5
Volume 10, Issue 5, May 2022, Page 297
Rising diabetes diagnosis in long COVID
K M VenkatNarayanabcdLisa RStaimezac
Levothyroxine treatment in euthyroid women positive for thyroid peroxidase antibodies and recurrent pregnancy loss
Tim I MKorevaaraRimaDhillon-Smithb
Targeting PCSK9 inhibitors to those who will benefit most
Traci ATurneraEvan ASteina
Dapagliflozin in young people with type 2 diabetes
Kalie LTommerdahlaRobert GNelsonbPetterBjornstada
Breakthrough technology for in-hospital glucose monitoring
DavidKerraDavidKlonoffbcd
Methodological considerations in D-health cancer mortality results
SamEggeraDavid PSmithaVisaliniNair-Shallikera
Methodological considerations in D-health cancer mortality results – Authors' reply
Rachel ENealeaaBriony DuarteRomeroaDonald S AMcLeodacDallas REnglishdeGunterHartelaJolieke Cvan der PolsfAlison JVenngPenelope MWebbabDavid CWhitemanabMaryWaterhousea
Caring for people with diabetes and non-communicable diseases in Ukraine: a humanitarian emergency
GalynaMaystrukaSigiriya AebischerPeronebValentynaAnufriyevacPhilippaBoulledFrançoisChappuisbBrunoLabbDavidBeranb
Diabetes in Pakistan: addressing the crisis
Zulfiqar ABhuttaabZiaUl HaqcAbdulBasitd
Risks and burdens of incident diabetes in long COVID: a cohort study
YanXieMPHacdZiyadAl-AlyMDabdef
Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Myrthe Mvan DijkMDaRosaVissenbergPhDcProfEricFliersMDbProfJoris A Mvan der PostMDaMarie-Louise Pvan der HoornPhDdSabinade WeerdPhDeWalter KKuchenbeckerPhDfProfAnnemiekeHoekMDgJ MarkoSikkemaPhDhHarold RVerhoevePhDiKimiko ABroezeMDjCorry Hde KoningPhDkProfWillemVerpoestMDlProfOle BChristiansenMDmnCarolienKoksPhDoJan Pde BruinPhDpDimitri N MPapatsonisPhDqHelenTorrancePhDr…ProfMariëtteGoddijnMDaâ€
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial
ProfPetrOstadalMDaProfPhilippe GabrielStegMDbcYannPoulouinMScdProfDeepak LBhattMDeProfVera ABittnerMDfProfTerrenceChuaMDgProfRafaelDiazSr MDhProfShaun GGoodmanMDijProfYongHuoMDkProfJohan WouterJukemaMDlmProfYuriKarpovMDnRobertPordyMDoMichelScemamaMDpProfMichaelSzarekPhDqrProfHarvey DWhiteDScsProfGregory GSchwartzMDtODYSSEY OUTCOMES Investigators*
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
ProfWilliam VTamborlaneMDa†ProfLori MLaffelMDb†NaimShehadehMDcdElviraIsganaitisMDbMichelleVan NameMDaJayanthaRatnayakePhDeCeciliaKarlssonMDfEnsioNorjavaaraMDf
Obesity in children and adolescents: epidemiology, causes, assessment, and management
HibaJebeilePhDabProfAaron SKellyPhDdGraceO'MalleyPhDefProfLouise ABaurPhDac
The relevance of T3 in the management of hypothyroidism
ProfDomenicoSalvatoreMDaTommasoPorcelliMDaMatthew DEttlesonMDbProfAntonio CBiancoMDb
